Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPWG ,11180 posts ,the most abused company with the most potential IMO.
Oh ya know.....news is coming..........
I am number one....and what the f$ is up with GRDO!
We'll soon see what the new year brings..........
Fair enough....
I wish I could go into details, but it's all just speculation right now...........
is there a verified R/S at this point though or is it still not sure?
Maybe, but they are supposed to be issuing some sort of dividend......
Are they doing another reverse split?
Just gotta wait and see how it plays out???
Hey ya soup....what is happening with WEHI? I am reading some negative messages on WEHI board, did this stock fall through?
I sure as heck hope so....
Will the penny market heat up soon???
TomVeale...Really? Dang!...142MPH on wire wheels with a leather bonnet strap to boot! That's pretty amazing I'd say.
I know enough about Loyal Truesdale and the Carrera Pan America to last for a lifetime...fun guy, huh?
Ever do biz with Terry's Jaguar in central Illinois?
Flatsixer
LOL! Silly Tom, that's a screen shot of a portion of one of my databases that contains the people in the Top 60 updated daily. Note that IH Admin hasn't posted for a month so he/they/she/it is no longer in the Number One position.
http://investorshub.advfn.com/boards/hot_people.asp
I have a bunch of databases, my two biggest ones having 2,000+ I-Hub people in them.
Here's the top portion of that same database 5 days later......
Note also that I think you need a few more person marks before I can include you in this particular database.
Tom,
Thanks for sharing. Sweet car! Cant beleive you got her going that fast.
That is very interesting. I think one of these events would be great to take part in. Bet you had a great time with the ladies, er, i mean, the other participants.
Cannonball 8000 is coming to the United States in 2010 (will be launching in 2009 i beleive). By then, i would like to be prepared to possibly take part in the event. Think it would be a great time - a memorable time for the rest of my life.
Just need to raise the cash, and the stock market recently is not helping in this activity!
Hi $P, Re: PanAm race........................
Nice lookin' Pit Fluff in those photos of yours. The La Carrera Panamericana is run in late October of each year. It starts near the Mexico - Guatamala border and runs the backbone of Mexico all the way to the U.S. border at Nuevo Laredo.
http://www.lacarrerapanamericana.com.mx/galeria07_preclasificacion.asp
The fellow with whom I shared a ride told me recently he's going back again this Fall. He's preparing several cars for clients for the event.
If you're a Pink Floyd fan, they were there with us in 2001 and made a nice video.
http://www.amazon.com/Carrera-Panamericana-David-Gilmour/dp/6302427355/ref=pd_bbs_sr_2?ie=UTF8&s=video&qid=1203454716&sr=1-2
They crashed all their Jags, we soldiered on to a 10th place finish in class in '91, 4th place in '92 and again in '94.
Here's our car:
The Mexican HWY Patrol clocked us at 142 MPH (227 KPH) down one long stretch of highway in northern Mexico. That old cat has long legs.
The Corona Girls were along for the advertising and promotion during this week long 3000 Km event.
Lots of fun,
Tom
Hey Tom!
Those girls are from the entertainment group Spearmint Rhino. They were hired by Cannonball 8000 (rally company based in UK ticker: EIGH) for their European rally (along with the Corona girls).
What is the La Carrera Panamericana? Is that a rally/race based in South America/Spain? And is it annual?
Hey $P, Are those photos from the La Carrera Panamericana?
I'm a two time graduate of that asylum.
Best regards,
Piloto Loco
aka
Tom
Gosh W, I don't even show up on the list!
Now I'm gonna go pout.
:-]
TV
$to©k_Pi©ker™, I am ROTFL. I just read a bunch of your posts, and I see now that your question was obviously tongue-in-cheek. I might start paying attention to your posts too.
Just wondering what they bring to the table - Jokes, specific investment advice, sports talk, bashing, hitting on chix etc... lol
Great sense/cents of humor!!!!
Maximum Security prison? ROTFL again!
I can use your name yet again, $to©k_Pi©ker™ (private joke between $to©k_Pi©ker™ and myself for anyone 'listening').
My advice is to do your own research (I won and then lost all the money in the stock market years ago). I only know these three people from my online experience with them, but I find them friendly, honest, and intelligent. penny_ta took awhile in the friendly department, I think because too many people try to contact him all day long so he doesn't have the time to chit-chat much.
penny_ta:
http://investorshub.advfn.com/boards/Profile.asp?User=52654
ClayTrader:
http://investorshub.advfn.com/boards/Profile.asp?User=89929
stervc:
http://investorshub.advfn.com/boards/Profile.asp?User=1551
By reading some of their posts, you'll be able to figure out what they have to offer.
I'm honored that I am the only female you have talked to since you got out of maximum security prison 15 years ago...and I thank you for the mark. I hope you can make enough money online that you don't end up back there.
Do you know what they have to offer by chance, or do you not know those personally?
Just wondering what they bring to the table - Jokes, specific investment advice, sports talk, bashing, hitting on chix etc... lol
I gave you a mark - your the only woman i have spoken with in 15 years since i just got out of maximum prison ;)
$to©k_Pi©ker™, I get to use your name on the board! ClayTrader, stervc, and penny_ta are the people who have risen the most quickly in the Top 60 in the year I've been here. I would assume that all three of them have something of value to offer other investor/traders. penny_ta can't be seen on the chart because he's in slot #11, but really #9, because two of the aliases are for Admin (in the top 10).
Have fun on your free Friday and thanks for stopping by.
EDIT: Well, MOMO has too, but I didn't want to mention him since I'm rooting for penny_ta, ClayTrader, and stervc.
That is incredible. Thanks woof! And no, i was not ignoring you - just waiting for free friday ;)
Looking to the future, I think I might have the answer to the question Who's #1 on iHUB? For those who believe in trends, check out this 8 day span of time. ClayTrader appears to be a rising star. Note: Look for Blue letters.
IMHO CIVY is just starting
CIVY moooooooooo-ving +.04
RE: CIVY, what's the scoop? TIA
Keep an eye on CIVY today for a hard bounce off of .10
Keep an eye on CIVY today for a hard bounce off of .10
seems like IAHL is moving up today now up by 28% not so bad after all.
ASII up and moving too up by 30%
IAHL looking good this AM
IAHL was awesome yesterday.... looking forward to see more today.
good day to you cheesofriezzz!
IAHL looks like ready for next leg up
Could not agree more with you Soup on the hard work. When boards meet a need like your board you start getting mega PM's regarding calls people make because who doesn't want to be recognized in this market:)
Best,
Sheff
Thanks Sheff! Boards are hard work! :)
Great job Soup with this board! Was great if even for a short time:)
Best,
Sheff
Thank you! PM me anytime......
I found it interesting seeing your posts. ;)
Well, this board has been an interesting experiment. I doubt I will continue.
Thanks to all that have participated!
CARN +32% - Posted by: TTOON
http://investorshub.advfn.com/boards/read_msg.asp?message_id=26005150&txt2find=carn+
In reply to: None Date:1/15/2008 1:04:38 PM
Post #of 240882
CARN(0.22)GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
Tuesday, January 15 2008 1:03 PM, EST PR Newswire "US Press Releases "
IRVING, Texas , Jan. 15 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that its wholly owned DelSite Biotechnologies, Inc. subsidiary has successfully completed preclinical toxicology studies of its GelVac(TM) nasal powder influenza vaccine under FDA-reviewed protocols. Successful toxicology studies in two animal models using the H5N1 (bird flu) antigen were required in order to proceed with a planned Phase I clinical trial later this year. The bird flu antigen used in these preclinical studies was from a non-egg-based source.
This vaccine candidate is believed to be the only nasal powder vaccine under development that, if approved, could be shipped without refrigeration to peoples' homes and self-administered in the event of a pandemic outbreak of avian bird flu.
The toxicology studies were conducted at Charles River Laboratories , Preclinical Services, Wilmington, MA , a contract research organization well known for its work in preclinical studies of viral antigens. After administering one or two doses to test subjects at the highest dose tested, testing results showed the vaccine is safe and nontoxic and thus established the base for moving into the Phase I clinical study of the vaccine in humans subject to normal FDA regulatory procedures.
Separately, DelSite successfully completed its second pre-IND meeting with the FDA last November, which was held at the request of the FDA to discuss and clarify protocols related to the use of the H5N1 antigen. Previously, a Phase I human safety study on the GelVac(TM) platform (without an antigen) showed the delivery platform was safe and well tolerated. The GelVac(TM) nasal powder formulation with the H5N1 vaccine antigen is planned to enter a Phase I study in 2008.
"The successful completion of these preclinical toxicology studies is a major milestone in developing this H5N1 vaccine based on our GelVac(TM) nasal powder technology," stated Carlton E. Turner, PhD, president and CEO of Carrington. "In addition, the completion of the second pre-IND meeting has clearly laid out the development path toward clinical studies. These developments further demonstrate the feasibility of the GelVac(TM) nasal powder platform technology which can greatly expand the availability and coverage of vaccines with its distinct advantages over current liquid needle-based and nasal mist formulation technologies."
Dr. Turner added, "There is a true paradigm shift underway in vaccines from the classical needle delivery to a more user-friendly application. FluMist(R) by MedImmune started the shift, and I believe our nasal powder technology will complete the shift to a patient-friendly vaccination formulation and will open up markets that cannot be served by current vaccines systems."
Dr. Yawei Ni, chief scientific officer of DelSite, added, "Our nasal powder vaccine platform has been shown to work with many antigens, is stable at room temperature, requires no needles, no preservatives, and no cold storage, and can be shipped free of the restrictive cold chain distribution systems associated with vaccines. Moreover, our system is particularly well suited for influenza pandemic preparedness, bio-defense applications, and vaccine coverage in areas lacking basic infrastructures."
GelVac(TM) powder platform possesses other distinct, practical features. The GelSite(R) polymer used in the formulation is derived from a natural source and is stable over four years at room temperature. The polymer binds to and stabilized proteins and peptides. An influenza vaccine incorporating a, non-egg based, H1N1 antigen in the GelVac(TM) formulation has been stable at ambient room temperature for 36 months.
The nasal cavity is increasingly recognized as the ideal immunization route since most infectious diseases enter the body through mucosal surfaces such as those found in the nasal cavity, the lungs, and the intestines. Nasal immunization not only induces a systemic response, but also induces mucosal response, providing protection at the entry point. GelVac(TM) is a novel in- situ gelling powder formulation for nasal delivery. The GelSite(R) polymer enables in-situ gelling of the vaccine powder, which changes into gel particles upon exposure to nasal fluids present in the nasal passage. This gel adheres to the mucosal lining and provides prolonged residence time and sustained antigen release that, in turn, increase antigen delivery.
About DelSite
Carrington's wholly owned subsidiary DelSite Biotechnologies, Inc. is developing its proprietary GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs and vaccines. DelSite is currently developing a nasal powder vaccine using its GelVac(TM) formula with the H5N1 avian flu antigen. This work is partially funded by two grants from NIAID ( National Institute of Allergy and Infectious Diseases ) of NIH ( National Institutes of Health ) under the Department of Health and Human Services .
A Drug Master File (DMF) has been filed with the FDA for GelSite(R) polymer which may be made in kilogram quantities under cGMP guidelines in an ISO-certified facility.
About Carrington
Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs. Carrington's technology is protected by more than 130 patents in 26 countries. Select products carry the CE mark, recognized by more than 20 countries around the world. For more information, visit www.carringtonlabs.com.
Certain statements in this release concerning Carrington may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to: subsequent changes in plans by the Company's management; delays or problems in formulation, manufacturing, distribution, production and/or launch of new finished products; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company's filings with the Securities & Exchange Commission .
SOURCE Carrington Laboratories, Inc.
CGHI +60% - Posted by: superclassic
In reply to: superclassic who wrote msg# 41665 Date:1/24/2008 3:16:50 PM
Post #of 41707
CGHI .0085/.009 8th-of-Jan http://biz.yahoo.com/e/070108/cghi.pk8-k.html
http://investorshub.advfn.com/boards/read_msg.asp?message_id=26248557&txt2find=cghi+
TPWR +27% - Posted by: uranium-pinto-beans
In reply to: None Date:1/24/2008 12:00:54 PM
Post #of 15676
TPWR got some at $.0014 looks like r/m
http://investorshub.advfn.com/boards/read_msg.asp?message_id=26239889&txt2find=tpwr+
TFRY +97% - Posted by: legalegaltx
In reply to: None Date:1/24/2008 9:45:46 AM
Post #of 1179810
TFRY now .07! alerted at .015
http://investorshub.advfn.com/boards/read_msg.asp?message_id=26232982&txt2find=tfry+
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
181
|
Created
|
01/13/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |